Cannabis-Based Medical Products Aid Primary Insomnia
TUESDAY, Sept. 2, 2025 -- Insomnia patients taking cannabis-based medicinal products report better quality sleep, according to a study published online Aug. 27 in PLOS Mental Health.
Arushika Aggarwal, from Imperial College London, and colleagues assessed changes in sleep-specific and general patient-reported outcome measures in individuals prescribed cannabis-based medicinal products for insomnia, as well as the incidence of adverse events. The analysis included 124 patients with primary insomnia identified from the U.K. Medical Cannabis Registry.
The researchers found that Single-Item Sleep Quality Scale scores showed improvement from baseline (2.66) to one (5.67), three (5.41), six (4.80), 12 (4.24), and 18 months (3.81). Generalized Anxiety Disorder-7 scores improved at all time points from baseline to 18 months. For the EuroQol-5 Dimension-5 Level dimensions of usual activities, pain/discomfort, anxiety/depression, and index values, there were also significant improvements. Eleven people (8.87 percent) reported a total of 112 adverse events, but none were disabling or life-threatening.
"These findings support the potential role of medical cannabis as a medical option where conventional treatments have proven ineffective, though further randomized trials are needed to confirm long-term efficacy," coauthor Simon Erridge, M.B.B.S., also from Imperial College London, said in a statement.
Several authors disclosed ties to Curaleaf Clinic, a licensed and regulated private clinic with specialist doctors who can prescribe medical cannabis to eligible patients.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Older Adults Can Regain Well-Being
THURSDAY, Sept. 25, 2025 -- Older adults can regain well-being, according to a study published online Sept. 24 in PLOS ONE. Mabel Ho, Ph.D., and Esme Fuller-Thomson, Ph.D...
Adherence to Safe Sleep Practices Declines During, After Infant Illness
WEDNESDAY, Sept. 24, 2025 -- Reported adherence to safe sleep practices appears to be low among caregivers of infants presenting to the emergency department for low-acuity illness...
Insomnia Linked to Cognitive Decline, Cognitive Impairment
WEDNESDAY, Sept. 10, 2025 -- Insomnia is associated with cognitive decline and risk for cognitive impairment (CI), according to a study published online Sept. 10 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.